EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A DNA‐Modularized STING Agonist with Macrophage‐Selectivity and Programmability for Enhanced Anti‐Tumor Immunotherapy

Yingzhi Chen, Ruike Li, Qiao Duan, Lingling Wu, Xinyi Li, Aoxiang Luo, Yongming Zhang, Na Zhao, Kai Cui, Wenwei Wu, Tize Liu, Jian-Bo Wan und 5 weitere

Advanced Science · 2024-08 · 11 (32)

DOI: 10.1002/advs.202400149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.06.2024. Verfasst von Yingzhi Chen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Chemical Biology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao…. Hauptthemen laut MEDLINE: Membrane Proteins, Immunotherapy, Macrophages, DNA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Excellent Academic Leader Programme of Shanghai Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The activation of cyclic GMP‐AMP (cGAMP) synthase (cGAS) and its adaptor, stimulator of interferon genes (STING), is known to reprogram the immunosuppressive tumor microenvironment for promoting antitumor immunity. To enhance the efficiency of cGAS‐STING pathway activation, macrophage‐selective uptake, and programmable cytosolic release are crucial for the delivery of STING agonists. However, existing polymer‐ or lipid‐based delivery systems encounter difficulty in integrating multiple functions meanwhile maintaining precise control and simple procedures. Herein, inspired by cGAS being a natural DNA sensor, a modularized DNA nanodevice agonist (DNDA) is designed that enable macrophage‐selective uptake and programmable activation of the cGAS‐STING pathway through precise self‐assembly. The resulting DNA nanodevice acts as both a nanocarrier and agonist. Upon local administration, it demonstrates the ability of macrophage‐selective uptake, endosomal escape, and cytosolic release of the cGAS‐recognizing DNA segment, leading to robust activation of the cGAS‐STING pathway and enhanced antitumor efficacy. Moreover, DNDA elicits a synergistic therapeutic effect when combined with immune checkpoint blockade. The study broadens the application of DNA nanotechnology as an immune stimulator for cGAS‐STING activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsImmunotherapyMacrophagesDNANucleotidyltransferasesAnimalsMiceTumor MicroenvironmentHumansDisease Models, AnimalNeoplasmsSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

DNA nanotechnologyaptamercGAS‐STINGcancer immunotherapydrug deliverytumor‐associated macrophages

Substanzen

Membrane ProteinsDNANucleotidyltransferasesSTING1 protein, humanSTING ProteinSting1 protein, mousecGAS protein, mouseCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • Department of Pharmacology and Chemical Biology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Institute of Molecular Medicine, Shanghai Key Laboratory of Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
  • Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau, 999078, China.
  • Department of Nephrology, the Affiliated Hospital of Hebei Engineering University, Hebei, 056038, China.
  • Department of Neurosurgery, Changzheng Hospital, Naval Medical University, Shanghai, 200003, China.

ORCID-Profile: Weihong Tan, Zeyu Xiao

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Excellent Academic Leader Programme of Shanghai Health Commission
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Chen, Y., Li, R., Duan, Q., Wu, L., Li, X., Luo, A., Zhang, Y., Zhao, N., Cui, K., Wu, W., Liu, T., Wan, J. B., Deng, L., Li, G., Hou, L., Tan, W., & Xiao, Z. (2024). A DNA‐Modularized STING Agonist with Macrophage‐Selectivity and Programmability for Enhanced Anti‐Tumor Immunotherapy. Advanced Science, 11(32). https://doi.org/10.1002/advs.202400149

Vancouver

Chen Y, Li R, Duan Q, Wu L, Li X, Luo A, et al. A DNA‐Modularized STING Agonist with Macrophage‐Selectivity and Programmability for Enhanced Anti‐Tumor Immunotherapy. Advanced Science. 2024;11(32). doi:10.1002/advs.202400149

BibTeX
@article{Chen2024,
  author = {Chen, Yingzhi and Li, Ruike and Duan, Qiao and Wu, Lingling and Li, Xinyi and Luo, Aoxiang and Zhang, Yongming and Zhao, Na and Cui, Kai and Wu, Wenwei and Liu, Tize and Wan, Jian-Bo and Deng, Liufu and Li, Guiying and Hou, Lijun and Tan, Weihong and Xiao, Zeyu},
  title = {A DNA‐Modularized STING Agonist with Macrophage‐Selectivity and Programmability for Enhanced Anti‐Tumor Immunotherapy},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {32},
  doi = {10.1002/advs.202400149}
}
Kostenlos starten →